Pandemic Perspectives: US FDA Wastes No Time In COVID-19 Emergency Use Authorization Reviews

 
• By Sue Sutter
  
Hand Holding Syringe, Vaccine Injection, Virus Background, Prevention of Covid-19, Coronavirus Disease
The FDA's average review time for COVID-19 vaccine EUAs is 22 days. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards